---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-071338"
form_type: "8-K"
ticker: "APVO"
cik: "0001671584"
company_name: "Aptevo Therapeutics Inc."
filed_at: "2024-06-10T23:59:59+00:00"
generated_at: "2026-06-01T05:19:03.317238+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Aptevo stockholders elect two directors, ratify Moss Adams as auditor for 2024

## Summary
- Daniel J. Abdun-Nabi and Grady Grant III elected to board with ~470K votes for each.
- Ratification of Moss Adams as independent auditor for 2024: 1,271,108 for, 232,874 against.
- Second Amended and Restated 2018 Stock Incentive Plan approved: 442,849 for, 355,401 against.
- Non-binding advisory vote on executive compensation approved: 436,765 for, 365,824 against.
- Broker non-votes of ~704K were present on director election and incentive plan proposals.

## SEC filing metadata
- accession: 0000950170-24-071338
- form_type: 8-K
- ticker: APVO
- cik: 0001671584
- company_name: Aptevo Therapeutics Inc.
- filed_at: 2024-06-10T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1671584/000095017024071338/0000950170-24-071338-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1671584/000095017024071338/apvo-20240607.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-071338
- JSON: https://secwatch.observer/filing/0000950170-24-071338.json
- Plain text: https://secwatch.observer/filing/0000950170-24-071338.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.